Reduced brain infarct volume and improved neurological outcome by inhibition of the NR2B subunit of NMDA receptors by using CP101, 606-27 alone and in combination with rt-PA in a thromboembolic stroke model in rats
- 1 February 2003
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 98 (2) , 397-403
- https://doi.org/10.3171/jns.2003.98.2.0397
Abstract
Object. A novel postsynaptic antagonist of N-methyl-d-aspartate (NMDA) receptors, CP-101,606-27 may attenuate the effects of focal ischemia. In current experiments, the authors investigated its neuroprotective effect alone and in combination with recombinant tissue plasminogen activator (rt-PA) in thromboembolic focal cerebral ischemia in rats. Methods. Forty-eight male Wistar rats underwent embolization of the right middle cerebral artery to produce focal cerebral ischemia. After random division into six groups (eight rats in each group), animals received: vehicle; low-dose (LD) CP-101,606-27, 14.4 mg/kg; high-dose (HD) CP-101,606-27, 28.8 mg/kg; rt-PA, 10 mg/kg; low-dose combination (LDC) CP-101,606-27, 14.4 mg/kg plus rt-PA, 10 mg/kg; or high-dose combination (HDC) CP-101,606-27, 28.8 mg/kg plus rt-PA, 10 mg/kg) 2 hours after induction of embolic stroke. Animals were killed 48 hours after the onset of focal ischemia. Brain infarction volume, neurobehavioral outcome, poststroke seizure activity, poststr...Keywords
This publication has 34 references indexed in Scilit:
- Glycoprotein IIb/IIIa Antagonist, Murine 7E3 F(ab′)2, and Tissue Plasminogen Activator in Focal Ischemia: Evaluation of Efficacy and Risk of Hemorrhage with Combination TherapyJournal of Cerebral Blood Flow & Metabolism, 2002
- CP‐101,606: An NR2B‐Selective NMDA Receptor AntagonistCNS Drug Reviews, 1998
- (3R,4S)-3-[4-(4-Fluorophenyl)-4-hydroxypiperidin-1-yl]chroman-4,7-diol: A Conformationally Restricted Analogue of the NR2B Subtype-Selective NMDA Antagonist (1S,2S)-1-(4-Hydroxyphenyl)-2- (4-hydroxy-4-phenylpiperidino)-1-propanolJournal of Medicinal Chemistry, 1998
- Effect of CP101,606, a Novel NR2B Subunit Antagonist of theN-Methyl-d-Aspartate Receptor, on the Volume of Ischemic Brain Damage and Cytotoxic Brain Edema After Middle Cerebral Artery Occlusion in the Feline BrainStroke, 1997
- Effects of the Novel NMDA Antagonists CP-98,113, CP-101,581 and CP-101,606 on Cognitive Function and Regional Cerebral Edema Following Experimental Brain Injury in the RatJournal of Neurotrauma, 1997
- NMDA receptor-dependent and -independent immediate early gene expression induced by focal mechanical brain injuryNeurochemistry International, 1995
- Safety and Tolerability of the Glutamate Antagonist CGS 19755 (Selfotel) in Patients With Acute Ischemic StrokeStroke, 1995
- Clinical Experience With Excitatory Amino Acid Antagonist DrugsStroke, 1995
- Cloning and expression of the ε4 subunit of the NMDA receptor channelFEBS Letters, 1992
- Brain temperature measurements in rats: A comparison of microwave and ambient temperature exposuresBioelectromagnetics, 1986